Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
出版年份 2021 全文链接
标题
Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore
作者
关键词
Human papillomavirus, Nonavalent vaccine, Bivalent vaccine, Cervical cancer, Cost-effectiveness, Transmission dynamic model
出版物
VACCINE
Volume 39, Issue 16, Pages 2255-2263
出版商
Elsevier BV
发表日期
2021-03-19
DOI
10.1016/j.vaccine.2021.03.040
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis
- (2020) Didik Setiawan et al. PLoS One
- Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
- (2020) Rashidul Alam Mahumud et al. PLoS One
- Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines
- (2018) Kine Pedersen et al. EUROPEAN JOURNAL OF CANCER
- Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis
- (2018) Horace C. W. Choi et al. BMC Medicine
- Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence
- (2017) C. SIGNORELLI et al. EPIDEMIOLOGY AND INFECTION
- 4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years
- (2017) Daron G. Ferris et al. PEDIATRICS
- Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage
- (2017) Triin Võrno et al. VACCINE
- Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria
- (2016) L. Boiron et al. BMC INFECTIOUS DISEASES
- Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine
- (2016) Harrell W. Chesson et al. JOURNAL OF INFECTIOUS DISEASES
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Response to Editorial: Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report
- (2016) VALUE IN HEALTH
- Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
- (2016) Jane J. Kim et al. JNCI-Journal of the National Cancer Institute
- Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States
- (2015) Marc Brisson et al. JNCI-Journal of the National Cancer Institute
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health and Economic Impact of Switching from a 4-Valent to a 9-Valent HPV Vaccination Program in the United States
- (2015) Marc Brisson et al. JNCI-Journal of the National Cancer Institute
- Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
- (2013) Mélanie Drolet et al. INTERNATIONAL JOURNAL OF CANCER
- Human Papillomavirus Type Distribution in Invasive Cervical Cancer and High-Grade Cervical Intraepithelial Neoplasia Across 5 Countries in Asia
- (2012) Swee Chong Quek et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Epidemiologic risk profile of infection with different groups of human papillomaviruses
- (2009) Paul K.S. Chan et al. JOURNAL OF MEDICAL VIROLOGY
- Health and Economic Implications of HPV Vaccination in the United States
- (2008) Jane J. Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started